Articles with "hla haploidentical" as a keyword



Photo by nci from unsplash

T‐cell depleted HLA‐haploidentical HSCT in a child with neuromyelitis optica

Sign Up to like & get
recommendations!
Published in 2019 at "Annals of Clinical and Translational Neurology"

DOI: 10.1002/acn3.50843

Abstract: Neuromyelitis optica is an immune‐mediated disease characterized by a relapsing course, resulting in progressive disability. In children, given the long life expectancy, a disease‐modifying treatment could be particularly desirable. Unfortunately, the currently available treatment strategies… read more here.

Keywords: neuromyelitis optica; cell depleted; hla haploidentical; hsct ... See more keywords
Photo from wikipedia

HLA-haploidentical transplantation for relapsed/refractory AML: better LFS with BM than with PBSC in patients ≥ 55 years of age.

Sign Up to like & get
recommendations!
Published in 2022 at "American journal of hematology"

DOI: 10.1002/ajh.26627

Abstract: The best stem cell source for T-cell replete HLA-haploidentical transplantation with post-transplant cyclophosphamide (PTCy) remains to be determined. In this EBMT retrospective study we analyzed the impact of stem cell source on leukemia-free survival (LFS)… read more here.

Keywords: patients years; hla haploidentical; years age; haploidentical transplantation ... See more keywords
Photo by nci from unsplash

HLA-haploidentical peripheral blood stem cell transplantation following reduced-intensity conditioning with very low-dose antithymocyte globulin for relapsed/refractory acute leukemia in pediatric patients: a single-institution retrospective analysis

Sign Up to like & get
recommendations!
Published in 2022 at "International Journal of Hematology"

DOI: 10.1007/s12185-021-03270-z

Abstract: The prognosis of relapsed/refractory (R/R) pediatric acute leukemia is extremely poor. We retrospectively reviewed 20 consecutive pediatric patients with R/R acute leukemia who underwent a first HLA-haploidentical peripheral blood stem cell transplantation following reduced-intensity conditioning… read more here.

Keywords: relapsed refractory; leukemia; hla haploidentical; pediatric patients ... See more keywords
Photo by nci from unsplash

Reconstitution of multifunctional CD56lowCD16low natural killer cell subset in children with acute leukemia given α/β T cell-depleted HLA-haploidentical haematopoietic stem cell transplantation

Sign Up to like & get
recommendations!
Published in 2017 at "OncoImmunology"

DOI: 10.1080/2162402x.2017.1342024

Abstract: ABSTRACT We recently described the CD56lowCD16low subset of Natural Killer (NK) cells that both mediate cytotoxic activity and produce IFNγ, being more abundant in bone marrow (BM) than in peripheral blood (PB) of pediatric normal… read more here.

Keywords: depleted hla; cd56lowcd16low cells; cell depleted; natural killer ... See more keywords
Photo from wikipedia

A prospective observational study of immune reconstitution following transplantation with post‐transplant reduced‐dose cyclophosphamide from HLA‐haploidentical donors

Sign Up to like & get
recommendations!
Published in 2019 at "Transplant International"

DOI: 10.1111/tri.13494

Abstract: Allogeneic hematopoietic cell transplantation (HCT) from HLA‐haploidentical donors with post‐transplantation high‐dose cyclophosphamide (PT/Cy‐haplo) now predominates worldwide. However, to our knowledge, no prospective study has compared immune reconstitution after PT/Cy‐haplo with that after conventional HCT. The… read more here.

Keywords: dose cyclophosphamide; haploidentical donors; transplantation; hla haploidentical ... See more keywords
Photo by ank_2809 from unsplash

A Prospective Study of an HLA-Haploidentical Peripheral Blood Stem Cell Transplantation Regimen Based on Modification of the Dose of Posttransplant Cyclophosphamide for Poor Prognosis or Refractory Hematological Malignancies

Sign Up to like & get
recommendations!
Published in 2022 at "Cell Transplantation"

DOI: 10.1177/09636897221112098

Abstract: The optimal dose of posttransplant cyclophosphamide (PTCy) for use in patients undergoing HLA-haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide (PTCy-haplo) has not been sufficiently examined. This study evaluates the safety and efficacy of HLA-haploidentical hematopoietic… read more here.

Keywords: transplantation; posttransplant cyclophosphamide; hla haploidentical; cell transplantation ... See more keywords
Photo from wikipedia

Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion.

Sign Up to like & get
recommendations!
Published in 2017 at "Blood"

DOI: 10.1182/blood-2017-04-779769

Abstract: Allogeneic hematopoietic stem cell transplantation (HSCT) from an HLA-haploidentical relative (haplo-HSCT) is a suitable option for children with acute leukemia (AL) either relapsed or at high-risk of treatment failure. We developed a novel method of… read more here.

Keywords: children acute; hsct; acute leukemia; hla haploidentical ... See more keywords
Photo from wikipedia

HLA-Haploidentical Family Donors: The New Promise for Childhood Acute Lymphoblastic Leukaemia?

Sign Up to like & get
recommendations!
Published in 2021 at "Frontiers in Pediatrics"

DOI: 10.3389/fped.2021.758680

Abstract: Allogeneic haematopoietic stem cell transplantation (HSCT) is indicated in children with high-risk, relapsed or refractory acute lymphoblastic leukaemia (ALL). HLA-matched grafts from cord blood and stem cell repositories have allowed patients without suitable sibling donors… read more here.

Keywords: leukaemia; acute lymphoblastic; hla haploidentical; family donors ... See more keywords